Â¥
7.94
Sep 27
New Key Statistics Module, Z-Score and F-Score
SHSE:600267 Key Ratios
Market Cap ¥ M | 9,590.52 |
Enterprise Value ¥ M | 12,998.82 |
P/E(ttm) | -- |
PE Ratio without NRI | 51.23 |
Forward PE Ratio | 21.46 |
Price/Book | 1.18 |
Price/Sales | 0.97 |
Price/Free Cash Flow | 6.39 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 9,556.00 |
EPS (TTM) ¥ | -0.06 |
Beneish M-Score | -3.04 |
10-y EBITDA Growth Rate % | 3.10 |
5-y EBITDA Growth Rate % | -3.10 |
y-y EBITDA Growth Rate % | -84.30 |
EV-to-EBIT | 123.12 |
EV-to-EBITDA | 123.12 |
PEG | -- |
Shares Outstanding M | 1,207.87 |
Net Margin (%) | -0.65 |
Operating Margin % | 3.91 |
Pre-tax Margin (%) | -0.87 |
Quick Ratio | 0.62 |
Current Ratio | 0.87 |
ROA % (ttm) | -0.35 |
ROE % (ttm) | -0.75 |
ROIC % (ttm) | 2.37 |
Dividend Yield % | -- |
Altman Z-Score | 1.39 |
SHSE:600267 Number of Guru Trades
SHSE:600267 Volume of Guru Trades
Gurus Latest Trades with SHSE:600267
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600267 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Hisun Pharmaceutical Co Ltd Insider Transactions
No Available Data